Common Stock, Shares, Outstanding of Arch Therapeutics, Inc. from 30 Sep 2011 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Arch Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2011 to 30 Jun 2024.
  • Arch Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 4,444,364, a 246% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Arch Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 4,444,364 +3,159,151 +246% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q3
Q1 2024 4,444,364 +3,169,759 +249% 31 Mar 2024 10-Q 09 May 2024 2024 Q2
Q4 2023 4,742,364 +3,492,932 +280% 31 Dec 2023 10-Q 20 Feb 2024 2024 Q1
Q3 2023 4,689,446 +3,436,712 +274% 30 Sep 2023 10-Q 19 Aug 2024 2024 Q3
Q2 2023 1,285,213 -235,709,557 -99% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q3
Q1 2023 1,274,605 -235,795,165 -99% 31 Mar 2023 10-Q 23 May 2023 2023 Q2
Q4 2022 1,249,432 -235,770,338 -99% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q1
Q3 2022 1,252,734 -235,467,036 -99% 30 Sep 2022 10-K 15 Feb 2024 2023 FY
Q2 2022 236,994,770 +275,000 +0.12% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 237,069,770 +350,000 +0.15% 31 Mar 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 237,019,770 +43,925,004 +23% 31 Dec 2021 10-Q 11 Feb 2022 2022 Q1
Q3 2021 236,719,770 +43,675,004 +23% 30 Sep 2021 10-K 28 Dec 2022 2022 FY
Q2 2021 236,719,770 +41,129,550 +21% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 236,719,770 +48,856,823 +26% 31 Mar 2021 10-Q 06 May 2021 2021 Q2
Q4 2020 193,094,766 +5,231,819 +2.8% 31 Dec 2020 10-Q 12 Feb 2021 2021 Q1
Q3 2020 193,044,766 +19,467,533 +11% 30 Sep 2020 10-K 17 Dec 2021 2021 FY
Q2 2020 195,590,220 +22,012,987 +13% 30 Jun 2020 10-Q 23 Jul 2020 2020 Q3
Q1 2020 187,862,947 +22,901,098 +14% 31 Mar 2020 10-Q 05 May 2020 2020 Q2
Q4 2019 187,862,947 +22,901,098 +14% 31 Dec 2019 10-Q 30 Jan 2020 2020 Q1
Q3 2019 173,577,233 +9,180,220 +5.6% 30 Sep 2019 10-K 11 Dec 2020 2020 FY
Q2 2019 173,577,233 +19,525,220 +13% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q3
Q1 2019 164,961,849 +10,909,836 +7.1% 31 Mar 2019 10-Q 14 May 2019 2019 Q2
Q4 2018 164,961,849 +10,909,836 +7.1% 31 Dec 2018 10-Q 01 Feb 2019 2019 Q1
Q3 2018 164,397,013 +10,704,156 +7% 30 Sep 2018 10-K 19 Nov 2019 2019 FY
Q2 2018 154,052,013 +3,282,971 +2.2% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q3
Q1 2018 154,052,013 +3,282,971 +2.2% 31 Mar 2018 10-Q 26 Apr 2018 2018 Q2
Q4 2017 154,052,013 +15,869,938 +11% 31 Dec 2017 10-Q 01 Feb 2018 2018 Q1
Q3 2017 153,692,857 +17,035,782 +12% 30 Sep 2017 10-K 18 Dec 2018 2018 FY
Q2 2017 150,769,042 +17,744,763 +13% 30 Jun 2017 10-Q 27 Jul 2017 2017 Q3
Q1 2017 150,769,042 +40,345,454 +37% 31 Mar 2017 10-Q 02 May 2017 2017 Q2
Q4 2016 138,182,075 +29,010,391 +27% 31 Dec 2016 10-Q 01 Feb 2017 2017 Q1
Q3 2016 136,657,075 +29,064,870 +27% 30 Sep 2016 10-K 15 Nov 2017 2017 FY
Q2 2016 133,024,279 +40,321,425 +43% 30 Jun 2016 10-Q 28 Jul 2016 2016 Q3
Q1 2016 110,423,588 +34,347,101 +45% 31 Mar 2016 10-Q 28 Apr 2016 2016 Q2
Q4 2015 109,171,684 +33,095,197 +44% 31 Dec 2015 10-Q 12 Feb 2016 2016 Q1
Q3 2015 107,592,205 +35,515,718 +49% 30 Sep 2015 10-K 05 Dec 2016 2016 FY
Q2 2015 92,702,854 +20,626,367 +29% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q3
Q1 2015 76,076,487 +4,150,000 +5.8% 31 Mar 2015 10-Q 07 May 2015 2015 Q2
Q4 2014 76,076,487 +15,931,250 +26% 31 Dec 2014 10-Q 09 Feb 2015 2015 Q1
Q3 2014 72,076,487 +11,931,250 +20% 30 Sep 2014 10-K 11 Dec 2015 2015 FY
Q2 2014 72,076,487 +13,431,275 +23% 30 Jun 2014 10-Q 06 Aug 2014 2014 Q3
Q1 2014 71,926,487 +65,896,487 +1093% 31 Mar 2014 10-Q 15 May 2014 2014 Q2
Q4 2013 60,145,237 +54,115,237 +897% 31 Dec 2013 10-Q 14 Feb 2014 2014 Q1
Q3 2013 60,145,237 +54,500,025 +965% 30 Sep 2013 10-K 12 Dec 2014 2014 FY
Q2 2013 58,645,212 +54,645,212 +1366% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q3
Q1 2013 6,030,000 31 Mar 2013 10-Q 20 May 2013 2013 Q2
Q4 2012 6,030,000 31 Dec 2012 10-Q 14 Feb 2013 2013 Q1
Q3 2012 5,645,212 +1,645,212 +41% 30 Sep 2012 10-K/A 01 May 2014 2013 FY
Q2 2012 4,000,000 30 Jun 2012 10-Q 14 Aug 2012 2012 Q3
Q3 2011 4,000,000 30 Sep 2011 10-K 31 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.